Siemens Acuson S2000 Ultrasound System

Overview Clinical Operational Technical

Superior architecture, advanced clinical applications and high resolution transducers deliver never before seen detail.

  • Dynamic TCE™ tissue contrast enhancement technology enhances borders and reduces speckle/noise on an entire volume, not just data “slices,” greatly improving subtle tissue differentiation
  • Advanced SieClear™ spatial compounding enhances anatomic border definition and improves tissue contrast; electronic beam steering rapidly acquires overlapping images from different view angles
  • Ultra high frequency 18L6 HD transducer incorporates twice the elements into half the spacing to improve slice thickness, image uniformity, and contrast resolution

Innovative Applications

The ACUSON S2000 system uses Siemens best-in-class proprietary micro-pinless (MP) transducer connector technology, optimized for high-frequency imaging, to support a complete suite of transducers for virtually every clinical application. You can go beyond conventional modes of 2D, 3D, 4D, and Doppler imaging to support a broad range of today’s most cutting-edge clinical applications:

  • Unique core acoustic technologies and state-of-the-art design provide precise details of complex pathology and subtle lesions in examinations
  • Virtual Touch™ applications* implement ARFI imaging technology to provide both qualitative regional and quantitative spot assessments of deep tissue stiffness
  • eSie Touch™ elasticity imaging software utilizes gentle manual compression to display high resolution relative tissue stiffness
  • Cadence™ contrast pulse sequencing technology (CPS)** provides a non-linear imaging technique to effectively separate and display tissue or contrast; excellent for lesion detection and characterization

*Virtual Touch applications are not yet commercially available in the USA.

**At the time of publication, the U.S. Food and Drug Administration has cleared ultrasound contrast agents only for use in LVO. Check the current regulation for the country in which you are using this system for contrast agent clearance.